Manon Lebrun – Trademark Portfolio
Entity Type: 01
Manon Lebrun holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 42 (Computer & Scientific) — 1 filings in this category. The portfolio also extends into Class 3 (Cosmetics & Cleaning) across 6 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include OZEADERMA. The owner is based in Boucherville Quebec.
911 MacKenzie Street
Boucherville Quebec J4B7L7 , CA
Showing of trademarks Trademarks
Trademark Classifications
Manon Lebrun's trademark portfolio spans 6 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Scientific and technological services; industrial analysis and research services
Bleaching preparations and other substances for laundry use; cleaning, polishing, scouring
Legal services; security services for the protection of property and individuals
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Frequently Asked Questions
How many trademarks does Manon Lebrun have?
Manon Lebrun has 1 U.S. trademark filed with the USPTO. Of these, 1 registered.
What trademark classes does Manon Lebrun file in?
Manon Lebrun files trademarks across 6 Nice Classification classes. The most active classes are Class 42 (Computer & Scientific), Class 3 (Cosmetics & Cleaning), Class 45 (Legal & Security Services), Class 10 (Medical Apparatus), Class 5 (Pharmaceuticals). Class 42 covers scientific and technological services; industrial analysis and research services.
What are Manon Lebrun's most well-known trademarks?
Manon Lebrun's registered trademark portfolio includes well-known marks such as OZEADERMA. These are among 1 currently registered trademark in the portfolio.
What is Manon Lebrun's trademark registration success rate?
Manon Lebrun has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.